158 related articles for article (PubMed ID: 26028992)
1. Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
Heby M; Elebro J; Nodin B; Jirström K; Eberhard J
BMC Clin Pathol; 2015; 15():10. PubMed ID: 26028992
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
[TBL] [Abstract][Full Text] [Related]
3. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
[TBL] [Abstract][Full Text] [Related]
4. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
Biomark Res; 2017; 5():10. PubMed ID: 28293425
[TBL] [Abstract][Full Text] [Related]
5. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
6. The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.
Lundgren S; Karnevi E; Elebro J; Nodin B; Karlsson MCI; Eberhard J; Leandersson K; Jirström K
J Transl Med; 2017 Jul; 15(1):152. PubMed ID: 28673320
[TBL] [Abstract][Full Text] [Related]
7. Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.
Borg D; Hedner C; Nodin B; Larsson A; Johnsson A; Eberhard J; Jirström K
BMC Clin Pathol; 2016; 16():13. PubMed ID: 27478410
[TBL] [Abstract][Full Text] [Related]
8. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
Boman K; Larsson AH; Segersten U; Kuteeva E; Johannesson H; Nodin B; Eberhard J; Uhlén M; Malmström PU; Jirström K
Br J Cancer; 2013 Jun; 108(11):2321-8. PubMed ID: 23652315
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
Larsson A; Johansson ME; Wangefjord S; Gaber A; Nodin B; Kucharzewska P; Welinder C; Belting M; Eberhard J; Johnsson A; Uhlén M; Jirström K
Br J Cancer; 2011 Aug; 105(5):666-72. PubMed ID: 21829192
[TBL] [Abstract][Full Text] [Related]
10. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
[TBL] [Abstract][Full Text] [Related]
11. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
12. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.
Elebro J; Heby M; Warfvinge CF; Nodin B; Eberhard J; Jirström K
PLoS One; 2016; 11(4):e0153533. PubMed ID: 27070783
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
Borg D; Larsson AH; Hedner C; Nodin B; Johnsson A; Jirström K
J Transl Med; 2018 Oct; 16(1):290. PubMed ID: 30355278
[TBL] [Abstract][Full Text] [Related]
14. Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas.
Heby M; Karnevi E; Elebro J; Nodin B; Eberhard J; Saukkonen K; Hagström J; Mustonen H; Seppänen H; Haglund C; Jirström K; Larsson AH
Sci Rep; 2020 Jun; 10(1):10373. PubMed ID: 32587323
[TBL] [Abstract][Full Text] [Related]
15. Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.
Heby M; Lundgren S; Nodin B; Elebro J; Eberhard J; Jirström K
J Transl Med; 2018 Mar; 16(1):66. PubMed ID: 29540182
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis.
Fristedt R; Elebro J; Gaber A; Jonsson L; Heby M; Yudina Y; Nodin B; Uhlén M; Eberhard J; Jirström K
PLoS One; 2014; 9(11):e112728. PubMed ID: 25397670
[TBL] [Abstract][Full Text] [Related]
17. Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.
Larsson AH; Nodin B; Syk I; Palmquist I; Uhlén M; Eberhard J; Jirström K
Diagn Pathol; 2013 Jul; 8():109. PubMed ID: 23819542
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
Andersson G; Wennersten C; Gaber A; Boman K; Nodin B; Uhlén M; Segersten U; Malmström PU; Jirström K
BMC Urol; 2014 May; 14():36. PubMed ID: 24885195
[TBL] [Abstract][Full Text] [Related]
19. Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
Wennersten C; Andersson G; Boman K; Nodin B; Gaber A; Jirström K
Diagn Pathol; 2014 Oct; 9():189. PubMed ID: 25278252
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment.
Lundgren S; Warfvinge CF; Elebro J; Heby M; Nodin B; Krzyzanowska A; Bjartell A; Leandersson K; Eberhard J; Jirström K
PLoS One; 2016; 11(6):e0156497. PubMed ID: 27275582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
